Role of vasoconstrictors in the systemic hypertension of rats acclimatized to hypoxia. Moue, Yoshihiro, Peter G. Smith, Richard L. Clancy, and Norberto C. Gonzalez. Department of Physiology, University of Kansas Medical Center, Kansas City, Kansas 66160-7401
APStracts 2:0295A, 1995.
Exposure to hypoxia (2-5 weeks) results in systemic hypertension in rats and in humans. The possible mechanism(s) were investigated in rats acclimatized (A) for 3 wks to barometric pressure 370 Torr, and in non-acclimatized littermates (NA), by administering [alpha] adrenergic (phentolamine, PHLM), angiotensin II (AII ANTAG), and arginine-vasopressin (V1 ANTAG) receptor antagonists. Both A and NA were studied in hypoxia (FIO2 0.10). Baseline mean arterial blood pressure (MABP) was higher in A than in NA: 126 +/- 4 vs 101 +/- 2 mmHg (p&LT0.05). Neither AII nor V1 ANTAG influenced baseline MABP; however, both contributed to MABP recovery after PHLM. After simultaneous blockade of AII and V1, PHLM lowered MABP by 65 +/- 2 and 45 +/- 3 mmHg in A vs NA, respectively (p&LT0.05). After combined blockade of the three systems, the smooth muscle relaxant sodium nitroprusside (SNP) did not further modify MABP, which remained higher in A. It is concluded that: 1. the hypertension in A is partly due to a higher [alpha] adrenergic tone; 2. neither AII nor AVP contribute to the hypertension, but participate in MABP control after PHLM; 3. no other vasoconstrictor agents operate in either group; 4. the higher MABP in A after SNP may reflect additional hypertensive mechanisms.

Received 14 December 1994; accepted in final form 28 June 1995.
APS Manuscript Number A1274-4.
Article publication pending Journal of Applied Physiology.
ISSN 1080-4757 Copyright 1995 The American Physiological Society.
Published in APStracts on 11 July 1995.